| FIBROGEN INC. NEW O.N. |
| USA |
| Gesundheit |
| US31572Q8814 / A419WK |
| 1FG0 (Frankfurt) / FGEN (NASDAQ) |
| FRA:1FG0, ETR:1FG0, 1FG0:GR, NASDAQ:FGEN |
| - |
| https://www.fibrogen.com/ |
|
FibroGen, Inc. is a US-based biopharmaceutical com..
>Volltext.. |
| 29.5 Mio. EUR |
| -23.72 Mio. EUR |
| 7.05 Mio. EUR |
| -31.4 Mio. EUR |
| 138.88 Mio. EUR |
| 34.35 EUR |
| 17.87 Mio. EUR |
| 100.21 Mio. EUR |
| -14.41 Mio. EUR |
| 3.28 |
| -95.63% |
| - |
| - |
| - |
| - |
| - |
| FIBROGEN |
| 29.12.25 |
|
||||
|
||||
|
||||
|